Although the expression of miR-17-92, which is coded by MIR17HG, the causative gene of Feingold syndrome type 2, is controlled with transcriptional regulation by MYCN, the study demonstrated the distinct molecular mechanisms between Feingold syndrome type 1 and 2 (97). The gene discussed is MYCN; the disease is Feingold syndrome type 2.